{"id":196,"date":"2019-10-19T23:23:40","date_gmt":"2019-10-20T03:23:40","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-14-beta-2-agonist\/"},"modified":"2023-01-10T17:19:51","modified_gmt":"2023-01-10T22:19:51","slug":"4-14-beta-2-agonist","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-14-beta-2-agonist\/","title":{"raw":"4.14 Beta-2 Agonists","rendered":"4.14 Beta-2 Agonists"},"content":{"raw":"Albuterol is a Beta-2 agonist.\r\n\r\n<strong>Mechanism of Action:<\/strong> Albuterol is a selective Beta-2 agonist primarily used to cause bronchodilation in the lungs. However, Beta-2 receptors in the heart can also be stimulated, causing cardiovascular side effects.\r\n\r\n<strong>Indications for Use:<\/strong>\u00a0 Albuterol is commonly used to treat asthma and chronic obstructive pulmonary disease (COPD).\r\n\r\n<strong>Nursing Considerations Across the Lifespan:<\/strong>\r\n\r\nMonitor respiratory rate, oxygen saturation, and lungs sounds before and after administration. If more than one inhalation is ordered, wait at least 2 minutes between inhalations. Use a spacer device to improve drug delivery, if appropriate.\r\n\r\nBeta-2 agonists are safe for administration in pediatric and older adult populations.\r\n\r\n<strong>Adverse Effects:<\/strong> Albuterol can cause hypersensitivity or paradoxical bronchospasm.\u00a0 It can also produce a clinically significant cardiovascular effect in some clients by causing increased heart rate and blood pressure, which may require the drug to be discontinued.\r\n\r\n<strong>Patient Teaching &amp; Education: <\/strong>Clients should remain consistent with the medication dosing regimen.\u00a0 Individuals should contact their healthcare provider if they experience ongoing shortness of breath unrelieved with medication therapy.\u00a0 If using an inhaler, the client should be sure to prime the inhaler prior to administering the dose of medication.\u00a0 The medication can cause an unusual taste in the mouth, so clients should rinse their mouth with water after each use.[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n<h1>Albuterol Medication Card<\/h1>\r\nNow let's take a closer look at the medication card on albuterol.[footnote]This work is a derivative of<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\"> Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>.[\/footnote][footnote]UpToDate (2021). Albuterol. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote] Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h2 class=\"textbox__title\">Medication Card 4.14.1: Albuterol<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Class:<\/strong> Beta-2 Agonist\r\n\r\n<strong>Prototypes:<\/strong> Albuterol\r\n<h3>Therapeutic Effects<\/h3>\r\n<ul>\r\n \t<li>bronchodilation<\/li>\r\n<\/ul>\r\n<h3>Administration<\/h3>\r\n<ul>\r\n \t<li>oral inhalation<\/li>\r\n \t<li>can be given IV and PO<\/li>\r\n \t<li>wait at least 2 minutes between inhalations<\/li>\r\n<\/ul>\r\n<h3>Indications<\/h3>\r\n<ul>\r\n \t<li>bronchodilation in asthma or COPD<\/li>\r\n \t<li>Off-label: treatment of hyperkalemia<\/li>\r\n<\/ul>\r\n<h3>Side Effects<\/h3>\r\n<ul>\r\n \t<li>Hypersensitivity<\/li>\r\n \t<li>Can cause paradoxical bronchospasm<\/li>\r\n \t<li>Report significantly increased heart rate and blood pressure, which may require the drug to be discontinued<\/li>\r\n<\/ul>\r\n<h3>Nursing Considerations<\/h3>\r\n<ul>\r\n \t<li>If more than 1 inhalation is ordered, wait at least 2 minutes between inhalations<\/li>\r\n \t<li>Use spacer device to improve drug delivery, if appropriate<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/div>","rendered":"<p>Albuterol is a Beta-2 agonist.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Albuterol is a selective Beta-2 agonist primarily used to cause bronchodilation in the lungs. However, Beta-2 receptors in the heart can also be stimulated, causing cardiovascular side effects.<\/p>\n<p><strong>Indications for Use:<\/strong>\u00a0 Albuterol is commonly used to treat asthma and chronic obstructive pulmonary disease (COPD).<\/p>\n<p><strong>Nursing Considerations Across the Lifespan:<\/strong><\/p>\n<p>Monitor respiratory rate, oxygen saturation, and lungs sounds before and after administration. If more than one inhalation is ordered, wait at least 2 minutes between inhalations. Use a spacer device to improve drug delivery, if appropriate.<\/p>\n<p>Beta-2 agonists are safe for administration in pediatric and older adult populations.<\/p>\n<p><strong>Adverse Effects:<\/strong> Albuterol can cause hypersensitivity or paradoxical bronchospasm.\u00a0 It can also produce a clinically significant cardiovascular effect in some clients by causing increased heart rate and blood pressure, which may require the drug to be discontinued.<\/p>\n<p><strong>Patient Teaching &amp; Education: <\/strong>Clients should remain consistent with the medication dosing regimen.\u00a0 Individuals should contact their healthcare provider if they experience ongoing shortness of breath unrelieved with medication therapy.\u00a0 If using an inhaler, the client should be sure to prime the inhaler prior to administering the dose of medication.\u00a0 The medication can cause an unusual taste in the mouth, so clients should rinse their mouth with water after each use.<a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-196-1\" href=\"#footnote-196-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/p>\n<h1>Albuterol Medication Card<\/h1>\n<p>Now let&#8217;s take a closer look at the medication card on albuterol.<a class=\"footnote\" title=\"This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain.\" id=\"return-footnote-196-2\" href=\"#footnote-196-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><a class=\"footnote\" title=\"UpToDate (2021). Albuterol. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-196-3\" href=\"#footnote-196-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a> Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h2 class=\"textbox__title\">Medication Card 4.14.1: Albuterol<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Class:<\/strong> Beta-2 Agonist<\/p>\n<p><strong>Prototypes:<\/strong> Albuterol<\/p>\n<h3>Therapeutic Effects<\/h3>\n<ul>\n<li>bronchodilation<\/li>\n<\/ul>\n<h3>Administration<\/h3>\n<ul>\n<li>oral inhalation<\/li>\n<li>can be given IV and PO<\/li>\n<li>wait at least 2 minutes between inhalations<\/li>\n<\/ul>\n<h3>Indications<\/h3>\n<ul>\n<li>bronchodilation in asthma or COPD<\/li>\n<li>Off-label: treatment of hyperkalemia<\/li>\n<\/ul>\n<h3>Side Effects<\/h3>\n<ul>\n<li>Hypersensitivity<\/li>\n<li>Can cause paradoxical bronchospasm<\/li>\n<li>Report significantly increased heart rate and blood pressure, which may require the drug to be discontinued<\/li>\n<\/ul>\n<h3>Nursing Considerations<\/h3>\n<ul>\n<li>If more than 1 inhalation is ordered, wait at least 2 minutes between inhalations<\/li>\n<li>Use spacer device to improve drug delivery, if appropriate<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-196-1\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-196-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-196-2\">This work is a derivative of<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\"> Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>. <a href=\"#return-footnote-196-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-196-3\">UpToDate (2021). Albuterol. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-196-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":90,"menu_order":14,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-196","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":150,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":6,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/196\/revisions"}],"predecessor-version":[{"id":1539,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/196\/revisions\/1539"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/150"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/196\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=196"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=196"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=196"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}